T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Total Current Assets
ÂĄ1.6B
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Total Current Assets
ÂĄ29.2B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
2%
Proya Cosmetics Co Ltd
SSE:603605
Total Current Assets
ÂĄ5.6B
CAGR 3-Years
35%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Total Current Assets
ÂĄ5.5B
CAGR 3-Years
58%
CAGR 5-Years
53%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Total Current Assets
ÂĄ8.3B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Total Current Assets
ÂĄ4.1B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Total Current Assets?
Total Current Assets
1.6B CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Total Current Assets amounts to 1.6B CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
46%

Over the last year, the Total Current Assets growth was 5%. The average annual Total Current Assets growth rates for Tongling Jieya Biologic Technology Co Ltd have been 38% over the past three years , 46% over the past five years .

Back to Top